404 filings
Page 6 of 21
6-K
9cbdg
8 Jun 21
Current report (foreign)
6:14am
6-K
peqov
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am
6-K
jxgde57
28 May 21
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
6:00am
6-K
y4mb mkc1
19 May 21
Current report (foreign)
6:00am
6-K
je6wze0mu wls3r0yhmz
11 May 21
Current report (foreign)
2:10pm
6-K
1ak8qj6 a9bjuvadcit4
5 May 21
Transparency notification received from The Capital Group
6:00am
6-K
ksekwno se8c
3 May 21
Galapagos creates new subscription right plans
6:00am
6-K
4w47km
29 Apr 21
Current report (foreign)
4:18pm
6-K
t2eavr3v3jeb
23 Apr 21
Current report (foreign)
6:05am
6-K
fv8j8i
9 Apr 21
Extension of lock-up period in Gilead-Galapagos collaboration agreement
6:00am
6-K
hzgb8w6l
26 Mar 21
Publication of the annual report and invitation to the ordinary shareholders’ meeting
6:00am
6-K
phjmgzj4
25 Mar 21
Galapagos appoints Bart Filius as President and Chief Operating Officer
6:00am
6-K
2je8ysuuhqu
25 Mar 21
Publication of the annual report and invitation to the The annual report for the financial year 2020, including a review of figures and performance, is available online at
12:00am
6-K
pr5cm3usxs npfqr25
22 Mar 21
Current report (foreign)
6:05am
6-K
f0vcl
4 Mar 21
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
6:05am
6-K
vvwq0
4 Mar 21
Transparency notification received from The Capital Group
6:00am
6-K
1qxj0tcybn8vnz
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
zhwhwote1
10 Feb 21
Current report (foreign)
11:31am
6-K
ur1 2ppjr
9 Feb 21
Current report (foreign)
4:34pm